Cargando…
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
BACKGROUND: Patients with inborn errors of immunity (IEI) are at increased risk of severe coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore of great importance in this group, but little is known about the immunogenicity of COVID-19 vaccines in these patients. O...
Ejemplares similares
-
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
por: van Leeuwen, Leanne P. M., et al.
Publicado: (2023) -
A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
por: van der Velden, Yme U., et al.
Publicado: (2022) -
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Brinkkemper, Mitch, et al.
Publicado: (2021) -
Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance
por: van de Peppel, Robert J, et al.
Publicado: (2021) -
Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern
por: van Rijswijck, Danique M. H., et al.
Publicado: (2022)